Infiniplex(אינפיניפלקס בע~מ) Company Profile: Funding, Investors & Partnerships

Infiniplex(אינפיניפלקס בע~מ)

Infiniplex is developing an ultra-specific, multiplexed qPCR/dPCR-based liquid biopsy platform for precision oncology. From a simple liquid biopsy sample- primarily plasma and urine - our technology can pick dozens of cancer mutations in 2-3 hours at 0.01-0.1% VAF, enabling real-time CDx (companion diagnostics), treatment monitoring, and MRD characterization use cases with NGS sensitivity and at PCR speed, cost, and accessibility.Infiniplex is developing an ultra-specific, multiplexed qPCR/dPCR-based liquid biopsy platform for p Show More

Alpha Score

34.6